According to SAMHSA, the urine Mandatory Guidelines took effect February 1, 2024, and the oral fluid Guidelines October 10, 2023. The major changes SAMHSA lists are revised timelines and procedures for drug testing panel changes, revised rules for reporting specimens as substituted based on biomarker testing, a process for publishing an authorized biomarker testing panel, a revised MRO verification process for positive codeine and morphine specimens, semiannual MRO reports on lab positives verified as negative and, for urine, a morphine confirmatory cutoff raised from 2,000 to 4,000 ng/mL. HHS proposed further revisions on October 29, 2026, which are not final.
Ready to get started?